NAVIDEA BIOPHARMACEUTICALS, INC. Current Assets
NAVIDEA BIOPHARMACEUTICALS, INC. had Current Assets of $4.50 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2023-11-14
- 2023-09-30: Assets, Current $4.50M.
- 2023-06-30: Assets, Current $7.00M.
- 2023-03-31: Assets, Current $1.20M.
- 2022-12-31: Assets, Current $3.20M.
| Period end | Assets, Current |
|---|---|
| 2023-09-30 | $4.50M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $7.00M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.20M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.20M 10-Q · filed 2023-11-14 |
| 2022-09-30 | $5.10M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.17M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.32M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.38M 10-K · filed 2023-03-27 |
| 2021-09-30 | $7.66M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $10.04M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $8.83M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $6.53M 10-K · filed 2022-03-28 |
| 2020-09-30 | $4.79M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $6.07M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.45M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.92M 10-K · filed 2021-03-26 |
| 2019-09-30 | $3.23M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $6.47M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.23M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $5.60M 10-K · filed 2020-03-18 |
| 2018-09-30 | $7.14M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $6.60M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $16.23M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $13.83M 10-K · filed 2019-03-15 |
| 2017-09-30 | $15.17M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $16.81M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $21.70M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $10.83M 10-K · filed 2018-03-15 |
| 2016-09-30 | $9.43M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $6.86M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $10.04M 10-Q · filed 2016-05-16 |
| 2015-12-31 | $12.58M 8-K · filed 2017-12-15 |
| 2015-09-30 | $14.96M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $19.53M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $8.02M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $8.60M 10-K · filed 2016-03-23 |
| 2014-09-30 | $13.98M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $20.57M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $29.52M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $37.33M 10-K · filed 2015-03-16 |
| 2013-09-30 | $47.62M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $28.73M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $12.03M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $10.62M 10-K · filed 2014-03-14 |
| 2012-09-30 | $12.17M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $18.69M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $23.51M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $30.05M 10-K/A · filed 2013-03-21 |
| 2011-09-30 | $32.88M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $11.38M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $10.23M 10-K · filed 2012-03-07 |